How to Cite
Abstract
There were analyzed epidemiological risk factors in 505 breast cancer patients receiving treatment in the Tashkent City Oncology Dispensary. The tumor was studied by the hormone-receptor status, the level of Her2/neu protein hyperexpression and proliferation index in tumor cells Ki 67. The risk of developing breast cancer was higher in women aged 40 to 60 years with the most adverse prognostic biological subtypes of breast cancer. The high incidence of hypothyroidism along with established epidemiological risk factor for breast cancer, such as obesity, was investigated.References
Берштейн Л. М., Семиглазов В. Ф. Подтипы рака молочной железы и их гормонально-метаболическое «обеспечение»: прикладной аспект // Вопр. онкол. - 2011. - Т. 57 (5). С. 559-566.
Кулигина Е. Ш. Эпидемиологические и молекулярные аспекты рака молочной железы // Практич. онкол. - 2010. - Т. - 11 (1). - С. 203-216.
Хансон К. П., Берштейн Л. М., Имянитов Е. Н. и др. Молекулярно- биологические и биохимические особенности рака молочной железы // Вестн. Росс. Академии наук - 1998. - № 1. С. 15-19.
Atchley D. P., Albarracin C. T., Lopez A. et al. Clinical and pathologic characteristics of patients with BRCA- positive and BRCA- negative brasy cancer // J Clin. Oncol. - 2008. - Vol. 26. - P. 4282-4288.
Coleman M. P., Quaresma M., Berrino F. et al. Cancer survival in five continents: a worldwide population- based study (CONCORD) // Lancet Oncol. - 2008. - Vol. 9. -P. 730-756.
Fiore E., Giustarini E., Mammoli C. et al. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer // J. Endocrinol. Invest. - 2007. - Vol. 30 (9). P. 734-738.
Gonsalez- Angulo A. M., Timms K. M., Liu S. et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer // Clin. Cancer Res. - 2011. Vol. 17. P. 1082-1089.
Lord S. J., Bernstein L., Johnson K. A. et al. Breast cancer risk and hormone receptor status in older women by parity, age at first birth, and breastfeeding: a case- control study // Cancer Epidemiology, Biomarkers and Prevention. - 2008. - Vol. 17 (7). P. 1723-3170.
Lund M. J., Butler E. N., Hair B. Y et al. Age/ race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population- based study and first report // Cancer. 2010. Vol. 116 (11). P. 2549- 2559.
MCPherson K., Steel C. M., Dixon J. M. ABC of breast diseases. Breast cancer epidemiology, risk factors, and genetics // B. M. J. 2000. - Vol. 321. P. 624- 628.
Turnbull C., Rohman N. Genetics predisposition to breast cancer: past, present and future // Ann. Rev. Genomics Hum. Genet. 2008. Vol. 9. P. 321.
Phipps A. I., Buist D. S., Malone K. A. et al. Reproductive history and risk of breast cancer subtypes defined by three biomarkers // Cancer Causes Control. - 2011. Vol. 22 (3). P. 399- 405.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...